Innovations in Home Care

Slides:

Advertisements

Similar presentations

The influence of Breast Cancer Pay for Performance Initiatives on breast cancer survival and performance measures: a pilot study in Taiwan Raymond NC Kuo,

Advertisements

In Which Areas Have Clinical Pharmacists Been the Most Successful in Patient Care ? Hospital inpatient unit (wards) –Therapeutic drug monitoring –Anticoagulation.

Obtaining Administrative Efficiencies with IT Support Nick FisherBabs Vogelsang Director of Clinical ResearchDirector of Information TechnologySiteman.

1115 Waiver Proposals California Children’s Services Program.

The Nurse’s Role in Inflammatory Bowel Disease

The Patient Experience With Systemic Lupus Erythematosus

Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.

Using the SafeMed model for transitions of care approach

The Nurse View Key Insights Along the CML Continuum

NOACs for Cancer-Associated Thrombosis:

RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL

Acute Heart Failure.

Barriers to Oral Anticoagulant Use for Stroke Prevention in AF

Thrombosis, Cancer, and NOACs

Does One Size Fit All in Obesity Management?

Access to NOAC Therapy:

Moderate-Intensity Statins for Dyslipidemia: How to Treat Today?

Anticoagulation Highlights From the American Heart Association Meeting 2017.

Obesity and Dyslipidemia: How Would You Treat?

Optimizing Outcomes With CT Imaging

Patient-Centered Care in Cystic Fibrosis

Neoadjuvant Therapy in HER2-Positive Breast Cancer

Optimizing Outcomes in the Management of GIST

Before and After: Patient Cases in Onychomycosis

Organizational Culture in the Oncology Medical Home

T-Cell Directed Therapy in MS

Panelists. Unique Perspectives on the Cost Burden of Diabetes in the United States.

What Do Primary Care Physicians Need to Know About Insulin/GLP-1 RA Fixed-Ratio Combinations?

nAMD: Switching Therapies - what you need to know

Using the SafeMed model for transitions of care approach

Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.

Best Practices in Chronic Myeloid Leukemia by Multidisciplinary Teams

Blood pressure control: dependence on adherence

Screening and Diagnosing Postpartum Depression

Counseling Patients About Germline BRCA Mutations

Assessing the State of Statin Therapy

Talking to Patients About Diabetes Management

PCP View: ACC/AHA Guidelines: Role of Moderate Intensity Statins

From Symptom Management to Communication in Advanced GI Cancers

Access to NOAC Therapy:

Program Goals. Single vs Dual HER2 Blockade for Metastatic HER2-Positive Breast Cancer.

What Anticoagulant Registries Are Revealing

A Better Solution For Cancer Patients With VTE?

From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP

Patient Selection, Pharmacoeconomics, and PCSK9 Inhibitors

Statins and HIV:.

Real-World Evidence in VTE

Evaluating New Therapies in HF

The Importance of Getting the Dose Right in HF

Multidisciplinary Management of Hyperkalemia:

Revisiting the Pharmacoeconomics of HF

Clinicians' Corner in Dyslipidemia

Assessing Atrial Fibrillation: Real-World Data vs Clinical Trials

When Is Intrathecal Drug Delivery Appropriate?

Cancer-Associated Thrombosis

Current Challenges in Managing Hemophilia

The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.

Application of Biologics in IBD:

Add-On Therapy to Insulin in T1DM Management

A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.

Communicating With Your Patients About Major Depressive Disorder

Program Goals Background: Anticoagulation in Patients With VTE.

Improving Adherence to Antiplatelet Therapy After an ACS Event

When Is Intrathecal Drug Delivery Appropriate?

The Changing Goals of CML Therapy

The Power of As-Treated Analyses

What Do the Guidelines Say About The Role of the HF Nurse?

Presentation transcript:

Innovations in Home Care

Why Cancer Care at Home?

Therapy Administered at Home

Cost of Inpatient Care

Newer Cancer Drugs

Patients Receiving Adjuvant Therapy

Factors Influencing Eligibility for Home Care

Challenges of Transfer of Care to Home

Adherence

Self-Reported Adherence vs MPR

Measuring Adherence Is a Challenge

Patient-Centered Cancer Care

Adherence to CML Therapy

Adherence Is Critical for Achieving Molecular Responses in CML

SC Administration

Omacetaxine SC

Hazards of SC

IV Infusions

Challenges in Treating Patients at Home

Barriers to Effective Home Care

Benefits of Treating Patients at Home

Patients Treated in Specialty Care Model

Changing Patient Engagement

Reengineering the Patient Relationship

Patients Desire Real-Time Care NOW

Risks and Precautions of Home Cancer Therapy

Cost Implications

Fully Engaged Patient Necessary for Best Outcomes

Summary

Abbreviations

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)